Glenn Greenberg - Brave Warrior Advisors,
Period:    Q1 2026
Portfolio date:    31 Mar 2026
No. of stocks:    36
Portfolio value:    $4,040,158,246
Holdings Activity Buys Sells    History
Holding/activity history for  Elevance Health Inc. (ELV)
Period Shares % of Portfolio Activity % Change to Portfolio Reported Price Value Filing
2026   Q1 1,122,308 8.13 Reduce 10.34% 1.06 $292.75 $328,555,667 SEC
2025   Q4 1,251,803 10.28 Reduce 31.74% 4.37 $350.55 $438,819,542 SEC
2025   Q3 1,834,002 13.76 Add 65.28% 5.43 $323.12 $592,602,726 SEC
2025   Q2 1,109,653 9.89 Reduce 29.66% 4.66 $388.96 $431,610,631 SEC
2025   Q1 1,577,570 15.72 Reduce 3.22% 0.48 $434.96 $686,179,847 SEC
2024   Q4 1,629,977 14.96 Reduce 0.70% 0.12 $368.90 $601,298,515 SEC
2024   Q3 1,641,413 17.71 Add 0.51% 0.09 $520.00 $853,534,760 SEC
2024   Q2 1,633,127 19.61 Reduce 0.77% 0.14 $541.86 $884,926,196 SEC
2024   Q1 1,645,837 17.85 Reduce 6.31% 1.25 $518.54 $853,432,318 SEC
2023   Q4 1,756,653 19.76 Add 7.93% 1.45 $471.56 $828,367,289 SEC
2023   Q3 1,627,598 17.69 Add 23.18% 3.33 $435.42 $708,688,721 SEC
2023   Q2 1,321,272 15.51 Add 21.80% 2.78 $444.29 $587,027,937 SEC
2023   Q1 1,084,768 15.43 Add 24.34% 3.02 $459.81 $498,787,174 SEC
2022   Q4 872,415 14.10 Reduce 26.68% 4.98 $512.97 $447,522,723 SEC
2022   Q3 1,189,871 18.68 Reduce 1.77% 0.35 $454.24 $540,487,000 SEC
2022   Q2 1,211,276 20.07 Reduce 10.49% 2.06 $482.58 $584,538,000 SEC
2022   Q1 1,353,249 19.61 Reduce 0.92% 0.19 $491.22 $664,743,000 SEC
2021   Q4 1,365,785 20.17 Reduce 0.40% 0.07 $463.54 $633,096,000 SEC
2021   Q3 1,371,262 17.90 Add 19.72% 2.95 $372.80 $511,206,000 SEC
2021   Q2 1,145,416 15.01 Reduce 1.57% 0.21 $381.80 $437,320,000 SEC
2021   Q1 1,163,729 13.64 Add 50.91% 4.60 $358.95 $417,720,000 SEC
2020   Q4 771,135 9.11 Add 0.94% 0.09 $321.09 $247,603,000 SEC
2020   Q3 763,927 9.16 Reduce 0.98% 0.10 $268.59 $205,183,000 SEC
2020   Q2 771,468 10.09 Reduce 11.88% 1.36 $262.98 $202,881,000 SEC
2020   Q1 875,467 11.44 Add 39.48% 3.24 $227.04 $198,766,000 SEC
2019   Q4 627,652 10.02 Reduce 1.68% 0.14 $302.03 $189,570,000 SEC
2019   Q3 638,397 8.18 Buy 8.18 $240.10 $153,279,000 SEC